150 related articles for article (PubMed ID: 9008877)
1. Killer factor interference in mixed opportunistic yeast cultures.
Conti S; Cantelli C; Gerloni M; Fisicaro P; Magliani W; Bertolotti D; Mozzoni P; Sullivan D; Coleman D; Polonelli L
Mycopathologia; 1996; 135(1):1-8. PubMed ID: 9008877
[TBL] [Abstract][Full Text] [Related]
2. Effect of Pichia anomala killer toxin on Candida albicans.
Mathews HL; Conti S; Witek-Janusek L; Polonelli L
Med Mycol; 1998 Aug; 36(4):199-204. PubMed ID: 9776835
[TBL] [Abstract][Full Text] [Related]
3. Serological study of yeast killer toxins by monoclonal antibodies.
Polonelli L; Manzara S; Conti S; Dettori G; Morace G; Chezzi C
Mycopathologia; 1989 Dec; 108(3):211-5. PubMed ID: 2515441
[TBL] [Abstract][Full Text] [Related]
4. Differential toxinogenesis in the genus Pichia detected by an anti-yeast killer toxin monoclonal antibody.
Polonelli L; Conti S; Campani L; Gerloni M; Morace G; Chezzi C
Antonie Van Leeuwenhoek; 1991 Apr; 59(3):139-45. PubMed ID: 1907819
[TBL] [Abstract][Full Text] [Related]
5. Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.
Polonelli L; Fanti F; Conti S; Campani L; Gerloni M; Castagnola M; Morace G; Chezzi C
J Immunol Methods; 1990 Sep; 132(2):205-9. PubMed ID: 2170534
[TBL] [Abstract][Full Text] [Related]
6. Physiological characteristics of the biocontrol yeast Pichia anomala J121.
Fredlund E; Druvefors U; Boysen ME; Lingsten KJ; Schnürer J
FEMS Yeast Res; 2002 Aug; 2(3):395-402. PubMed ID: 12702290
[TBL] [Abstract][Full Text] [Related]
7. Anti-Candida albicans activity of Pichia anomala as determined by a growth rate reduction assay.
Sawant AD; Abdelal AT; Ahearn DG
Appl Environ Microbiol; 1988 May; 54(5):1099-103. PubMed ID: 3291760
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of yeast killer toxin monoclonal antibodies.
Polonelli L; Morace G
J Clin Microbiol; 1987 Feb; 25(2):460-2. PubMed ID: 2434524
[TBL] [Abstract][Full Text] [Related]
9. Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis.
Séguy N; Polonelli L; Dei-Cas E; Cailliez JC
FEMS Immunol Med Microbiol; 1998 Sep; 22(1-2):145-9. PubMed ID: 9792073
[TBL] [Abstract][Full Text] [Related]
10. Human natural yeast killer toxin-like candidacidal antibodies.
Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
[TBL] [Abstract][Full Text] [Related]
11. Production of yeast killer toxin in experimentally infected animals.
Polonelli L; Conti S; Gerloni M; Campani L; Mantovani MP; Morace G
Mycopathologia; 1990 Jun; 110(3):169-75. PubMed ID: 2201918
[TBL] [Abstract][Full Text] [Related]
12. Immuno-crossreactivity of an anti-Pichia anomala killer toxin monoclonal antibody with a Williopsis saturnus var. mrakii killer toxin.
Guyard C; Evrard P; Corbisier-Colson AM; Louvart H; Dei-Cas E; Menozzi FD; Polonelli L; Cailliez J
Med Mycol; 2001 Oct; 39(5):395-400. PubMed ID: 12054049
[TBL] [Abstract][Full Text] [Related]
13. Interactions between killer yeasts and pathogenic fungi.
Walker GM; McLeod AH; Hodgson VJ
FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of killer yeast strains in industrial and clinical yeast isolates.
Baeza ME; Sanhueza MA; Cifuentes VH
Biol Res; 2008; 41(2):173-82. PubMed ID: 18949135
[TBL] [Abstract][Full Text] [Related]
15. Involvement of a cell wall receptor in the mode of action of an anti-Candida toxin of Pichia anomala.
Sawant AD; Ahearn DG
Antimicrob Agents Chemother; 1990 Jul; 34(7):1331-5. PubMed ID: 2201251
[TBL] [Abstract][Full Text] [Related]
16. Killer systems and pathogenic fungi.
Polonelli L; Morace G
Eur J Epidemiol; 1988 Dec; 4(4):415-8. PubMed ID: 3203721
[TBL] [Abstract][Full Text] [Related]
17. Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine.
Pettoello-Mantovani M; Nocerino A; Polonelli L; Morace G; Conti S; Di Martino L; De Ritis G; Iafusco M; Guandalini S
Gastroenterology; 1995 Dec; 109(6):1900-6. PubMed ID: 7498655
[TBL] [Abstract][Full Text] [Related]
18. From yeast killer toxins to antibiobodies and beyond.
Magliani W; Conti S; Travassos LR; Polonelli L
FEMS Microbiol Lett; 2008 Nov; 288(1):1-8. PubMed ID: 18785931
[TBL] [Abstract][Full Text] [Related]
19. Anaerobic yeast killer systems.
Polonelli L; Menozzi MG; Campani L; Gerloni M; Conti S; Morace G; Chezzi C
Eur J Epidemiol; 1992 May; 8(3):471-6. PubMed ID: 1397211
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical Activities of Hog1 Control Sensitivity of
Morales-Menchén A; Navarro-García F; Guirao-Abad JP; Román E; Prieto D; Coman IV; Pla J; Alonso-Monge R
Front Cell Infect Microbiol; 2018; 8():135. PubMed ID: 29774204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
